Biotech News
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
ir.foghorntx.com2026-05-06 15:04 EST
CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the 8 th